What we do
During the initial period, ATB has launched various second-brand oncology products, particularly those for colorectal and ovarian cancer. Together with the quality proven products and reasonable prices, ATB has continuously put substantial efforts to establish its corporate image among clinicians, pharmacists and healthcare providers. From time to time, it has allowed ATB to penetrate into the market and become one of its sustainable competitive advantages.
To best serve local market demands, ATB has then moved forward to locally initiate Thai new chemical entities (Thai NCEs). In presence, ATB has successfully transformed itself into the marketing-driven pharmaceutical arena.